𝔖 Scriptorium
✦   LIBER   ✦

πŸ“

Fraud and Misconduct in Biomedical Research

✍ Scribed by Farthing, Michael; Wells, Frank


Publisher
CRC Press
Year
2008
Tongue
English
Leaves
311
Edition
4th ed
Category
Library

⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis


Contributors Preface SECTION 1: SETTING THE SCENE 1. The concept of scientific dishonesty: Ethics, value systems, and research - Povl Riis 2. Ethical issues in the publication process - Richard Smith 3. What is research misconduct? - Drummond Rennie and C Kristina Gunsalus SECTION 2: THE HISTORICAL ASPECTS OF RESEARCH MISCONDUCT 4. An interpretive history of research misconduct policy in the USA and Canada - Β Read more...


Abstract: Contributors Preface SECTION 1: SETTING THE SCENE 1. The concept of scientific dishonesty: Ethics, value systems, and research - Povl Riis 2. Ethical issues in the publication process - Richard Smith 3. What is research misconduct? - Drummond Rennie and C Kristina Gunsalus SECTION 2: THE HISTORICAL ASPECTS OF RESEARCH MISCONDUCT 4. An interpretive history of research misconduct policy in the USA and Canada - Nicholas H Steneck 5. Historical aspects of research misconduct: Europe - Frank Wells SECTION 3: THE PREVENTION OF RESEARCH MISCONDUCT 6. The promotion of good publication practice - Elizabeth Wager 7. Monitoring medical research: Better to prevent than to cure? - Helena van den Dungen 8. The role of research ethics committees - John Saunders SECTION 4: APPROACHES TO THE DETECTION OF RESEARCH MISCONDUCT 9. The role of the whistleblower - Sabine Kleinert 10. The role of the peer review process - Ana Marusic 11. Can statistical analysis reveal research misconduct? - Stephen Evans 12. The role of electronic tracking in monitoring data output in clinical trials - Erick Gaussens, Pierre-Henri Bertoye, and Jean-Marc Husson 13. The role of monitoring of research for compliance and detecting misconduct - Michael R Hamrell 14. The role of routine enhanced audit - Nicky Dodsworth SECTION 5: INVESTIGATION OF RESEARCH MISCONDUCT 15. Handling whistleblowers: Bane and boon - C Kristina Gunsalus and Drummond Rennie 16. Conduct of an inquiry into alleged misconduct - Jane Barrett SECTION 6: THE WAY FORWARD 17. The role of national advisory bodies - Michael Farthing Index

✦ Table of Contents


Content: FRAUD AND MISCONDUCT IN BIOMEDICAL RESEARCH --
Contents --
Contributors --
Preface --
SECTION 1 SETTING THE SCENE --
1 The concept of scientific dishonesty: Ethics, value systems, and research --
Introduction --
Definitions --
Research --
Value systems --
Ethics --
Value universes of biomedical research --
Why do scientists transgress? --
What is the driving force for fraud? --
Scientific dishonesty in relation to its nature, prevalence, and consequences --
Good scientific practice --
New biomedical research methods --
Globalization of research ethics --
Social transfer of values --
Value conservation and the control of scientific dishonesty --
Conclusions --
References --
2 Ethical issues in the publication process --
Introduction --
Patient consent for case reports --
Informed consent for research --
Checking approval from research ethics committees or β„—Ζ―institutional review boards --
Failure to publish and publishing too much --
Conflict of interest --
Peer review --
Authorship or contributorship? --
Developing world --
Relating to the mass media --
Acting on ethical problems --
Support and accountability for editors --
Journals and business ethics --
Conclusion --
References --
3 What is research misconduct? --
Introduction --
Can formal definitions be avoided if good research practices are promoted? --
Why do we need a definition? --
What should our approach to a definition be? --
Jerks or crooks? --
Definition: the importance of uniformity --
Conditions and criteria necessary for any workable system --
Experience in the USA --
The scientific dialogue model --
The early 1990s: the heat increases --
The reaction --
The US government-wide regulations of December 2000 --
Lessons from the US experience --
What factors hold reform back? Professional societies --
The UK --
The Committee on Publication Ethics (COPE). The Joint Consensus Conference of 1999 Statement --
The UK Medical Research Council and the Wellcome Trust --
The UK Research Integrity Office (UKRIO) and other countries --
Conclusions --
References --
SECTION 2 THE HISTORICAL ASPECTS OF RESEARCH MISCONDUCT --
4 An interpretive history of research misconduct policy in the USA and Canada --
Introduction --
Pre-policy period (1981-85) --
Policy development (1985-93) --
Policy definition (1993-2000) --
Recent policy developments (2000 onwards) --
Research misconduct policy in Canada --
Analysis and conclusions --
References --
5 Historical aspects of research misconduct: Europe --
Introduction --
The Pearce case --
Classic cases of misconduct: the UK --
Misconduct in Europe --
National bodies on scientific integrity --
Recent cases: Europe --
Recent cases: the UK --
no research ethics committee approval --
Case 1 --
Case 2 --
Case 3 --
Case 4 --
Case 5 --
Registration of clinical trials --
Publication issues --
The ethical review process --
Fraud and misconduct policies --
Conclusions --
References --
SECTION 3 THE PREVENTION OF RESEARCH MISCONDUCT --
6 The promotion of good publication practice --
Introduction --
ICMJE Uniform Requirements --
Individual journal instructions to authors/contributors --
Good Publication Practice for pharmaceutical companies --
Guidelines for medical writers --
Statements from editors' organizations --
Journal peer-review practices --
Institutional guidelines --
Preventing plagiarism --
Punishment as a deterrent --
Conclusions --
References --
7 Monitoring medical research: Better to prevent than to cure? --
Why and how to monitor the quality and safety of medical research data --
Increase in regulation --
Quality of data --
Monitoring by the regulatory authorities --
Pharmacovigilance inspections --
Investigator site inspections --
Sponsor inspections. Inspections by ethics committees and institutional review boards --
Other inspection types --
Inspection findings --
Fraud and misconduct --
Size of the problem --
Resources --
Cure --
Prevention --
References --
8 The role of research ethics committees --
Introduction --
Guidelines and codes of practice --
Differing roles of RECs --
Fraud and misconduct --
Scientific review --
Suitability of investigators --
Financial issues --
Registration and publication of research projects --
Recruitment of research ethics committee members --
References --
SECTION 4 APPROACHES TO THE DETECTION OF RESEARCH MISCONDUCT --
9 The role of the whistleblower --
Introduction --
The status of whistleblowing --
The postgraduates who used the media to blow the whistle --
The technician who succeeded despite whistleblowing --
The independent whistleblower who read a published paper --
The researcher who wanted to check the data that were going to be published under his name --
Whistleblower legislation in selected countries --
US whistleblower protection laws --
UK whistleblower protection law --
Australian legislation --
A new whistleblower law in Norway --
Conclusions --
References --
10 The role of the peer review process --
Introduction --
Preventing publication misconduct --
Guidelines for authors and reviewers --
Guidelines and codes of practice for editorial work --
Detecting publication misconduct --
Detecting repetitive and divided publication and plagiarized work --
Detecting citations of retracted articles --
Verifying accuracy of references --
Detecting manipulation of images and numerical data --
Handling allegations of publication misconduct --
Allegations of misconduct before article publication --
Allegations of misconduct after article publication --
Conclusions --
References --
11 Can statistical analysis reveal research misconduct? --
Introduction. Characteristics of data --
Genuine data --
Altered data --
Invented data --
Misconduct that does not involve fabrication or falsification --
Deliberate selection of inappropriate analysis methods to obtain a desired result --
Misuse of subgroups --
Methods of analysis that might reveal altered or invented data --
Descriptive statistics --
univariable --
Descriptive statistics for bivariate or multivariate data --
Inferential statistics --
Baseline comparisons in randomized controlled trials --
Descriptive statistics of changes --
Exaggerated effects and random noise --
Examples --
Testing statistical methods using invented data --
Statistical methods used to detect actual misconduct --
What can editors and journals do? --
Conclusions --
References --
12 The role of electronic tracking in monitoring data output in clinical trials --
Introduction --
Inspection duties and powers within the information technologies (IT) environment --
Electronic tracking and computerized systems in the clinical sphere: the context --
The impact of the electronic world on fraud and misconduct --
Case reports --
The various computerized systems involved in clinical trials and their functional interactions --
How to track the correctness and reliability of the data within each of these systems: 21 CFR Part 11 and validation --
Systems are interrelated and disseminated: the need for standards such as CDISC --
Some advanced approaches: how to explore databases and combinations of data and documents --
Conclusions --
Glossary --
References --
Appendix: CDISC references and links with HL7 --
13 The role of monitoring of research for compliance and detecting misconduct --
Introduction --
Trial design considerations --
Selection of investigators --
Role of the monitor --
Detecting and dealing with non-compliance --
Research misconduct --
Detecting fraud and misconduct. Use of computers --
Preventing misconduct --
Dealing with misconduct --
Future prospects --
References --
14 The role of routine enhanced audit --
Introduction --
Auditor qualities and skills --
Audit planning --
Audit preparation --
Audit conduct --
The audit report --
Audit follow-up --
Conclusions --
References --
SECTION 5 INVESTIGATION OF RESEARCH MISCONDUCT --
15 Handling whistleblowers: Bane and boon --
Introduction --
What are whistleblowers and why should anyone care? --
Whistleblowers: a definition --
Challenges in discovering and responding to wrongdoing --
Practical advice for responding to whistleblowers --
Policies and people --
Provide clear guidance: policies, procedures, protections, and resources --
Devise institutional responses understanding the concerns of the whistleblower --
Make policies and help easy to find --
Provide choices for reporting --
Do not make reporting a duty --
Do not promise confidentiality to a whistleblower when you might not be able to honour the promise --
Take steps to prevent retaliation against the whistleblower --
Assign responsibilities carefully --
Devise systems for separating personalities from facts. Train those responsible for conducting and presiding over investigations --
What are the right questions to ask? --
Assess allegations consistently and even-handedly. Have a set of standards for assessing allegations --
Protect against conflicts of interest --
Seek professional support for investigations --
Carpe data --
Conclusions --
References --
16 Conduct of an inquiry into alleged misconduct --
Introduction --
Allegations of fraud or misconduct --
Who should handle allegations? --
Pitfalls in handling allegations of research misconduct --
Best practice --
Is there a case to be answered? --
Investigations --
The role of an independent investigator --
Conclusions --
References.

✦ Subjects


Medicine


πŸ“œ SIMILAR VOLUMES


Fraud and Misconduct in Biomedical Resea
✍ Frank Wells, Michael Farthing πŸ“‚ Library πŸ“… 2001 πŸ› BMJ Books 🌐 English

The definitive and only book in the world which deals exclusively with clinical research misconduct, recognising that - although it is not rife - its occurance at all requires recognition and action.

Research Fraud in the Behavioral and Bio
✍ David J. Miller, Michel Hersen (eds.) πŸ“‚ Library πŸ“… 1992 πŸ› John Wiley & Sons 🌐 English

While there is currently no official consensus as to the extent of fraud or misrepresentation in the sciences, recent estimates suggest that they may occur in as much as 12% of all scientific research conducted in North America. In an age dominated philosophically by the overarching ideal of scienti

Bioimpedance in Biomedical Applications
✍ Franco Simini, Pedro Bertemes-Filho πŸ“‚ Library πŸ“… 2018 πŸ› Springer International Publishing 🌐 English

<p>This book is based on the best contributions to the advancement of bioimpedance knowledge and use from the Latin American Congress series, CLABIO. Basic bioimpedance facts as well as promising and original contributions to bioimpedance theory and applications are presented, giving the reader stim

The Economics of Scientific Misconduct:
✍ James R. Wible πŸ“‚ Library πŸ“… 2022 πŸ› Routledge 🌐 English

The Economics of Scientific Misconduct explores episodes of misconduct in the natural and biomedical sciences and replication failure in economics and psychology over the past half-century. Here scientific misconduct is considered from the perspective of a single discipline such as economics likely